---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-040113"
form_type: "8-K"
ticker: "BFRI"
cik: "0001858685"
company_name: "Biofrontera Inc."
filed_at: "2023-11-09T23:59:59+00:00"
generated_at: "2026-06-08T07:43:31.827511+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Biofrontera Q3 revenue doubles to $8.9M; net loss widens to $6.3M

## Summary
- Total revenues $8.9M, up 106% YoY, driven by Ameluz adoption and price increase.
- Net loss of $6.3M ($4.64 per share) vs net loss of $2.6M ($2.26 per share) in Q3 2022.
- Cash and cash equivalents $3.4M; investment in Biofrontera AG shares valued at $3.3M.
- Raised $4.5M in registered direct offering at-the-market on November 2, 2023.
- Affirms FY2023 revenue growth at least 25% vs 2022; expects cash flow positive within ~1.5 years.

## SEC filing metadata
- accession: 0001493152-23-040113
- form_type: 8-K
- ticker: BFRI
- cik: 0001858685
- company_name: Biofrontera Inc.
- filed_at: 2023-11-09T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1858685/000149315223040113/0001493152-23-040113-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1858685/000149315223040113/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-040113
- JSON: https://secwatch.observer/filing/0001493152-23-040113.json
- Plain text: https://secwatch.observer/filing/0001493152-23-040113.txt

## Key facts
- Earnings Releases
  Biofrontera Inc. reported three and nine months ended September 30, 2023 results: revenue $8.9 million, net income $(4.64) per share, EPS $(4.64) per share. Guidance reaffirmed.
  - Period: three and nine months ended September 30, 2023
  - Revenue: $8.9 million
  - Net income: $(4.64) per share
  - EPS: $(4.64) per share
  - Guidance: reaffirmed
  - Result: reported results
  source text: Total revenues for the third quarter of 2023 were $8.9 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1858685/000149315223040113/0001493152-23-040113-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.